Theriva Biologics, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Theriva Biologics, Inc. annual/quarterly Return On Assets history and growth rate from 2012 to 2023.
  • Theriva Biologics, Inc. Return On Assets for the quarter ending December 31, 2022 was -24.7 %, a 30.7% decline year-over-year.
  • Theriva Biologics, Inc. annual Return On Assets for 2023 was -29.4 %, a 18.7% decline from 2022.
  • Theriva Biologics, Inc. annual Return On Assets for 2022 was -24.7 %, a 30.7% decline from 2021.
  • Theriva Biologics, Inc. annual Return On Assets for 2021 was -18.9 %, a 82.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -29.4 -4.63 -18.7% Jan 1, 2023 Dec 31, 2023
2022 -24.7 -5.8 -30.7% Jan 1, 2022 Dec 31, 2022
2021 -18.9 +89.4 +82.5% Jan 1, 2021 Dec 31, 2021
2020 -108 -39.3 -56.8% Jan 1, 2020 Dec 31, 2020
2019 -69.1 +17.4 +20.1% Jan 1, 2019 Dec 31, 2019
2018 -86.5 -6.18 -7.7% Jan 1, 2018 Dec 31, 2018
2017 -80.3 +75.8 +48.6% Jan 1, 2017 Dec 31, 2017
2016 -156 +20.5 +11.6% Jan 1, 2016 Dec 31, 2016
2015 -177 -3.51 -2.03% Jan 1, 2015 Dec 31, 2015
2014 -173 -62.5 -56.5% Jan 1, 2014 Dec 31, 2014
2013 -111 +85.3 +43.5% Jan 1, 2013 Dec 31, 2013
2012 -196 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.